• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索癌症的基因交响乐:癌基因与肿瘤抑制基因之间的相互作用。

Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes.

作者信息

Singh Sajal Raj, Bhaskar Rakesh, Ghosh Shampa, Yarlagadda Bhuvaneshwar, Singh Krishna Kumar, Verma Prashant, Sengupta Sonali, Mladenov Mitko, Hadzi-Petrushev Nikola, Stojchevski Radoslav, Sinha Jitendra Kumar, Avtanski Dimiter

机构信息

GloNeuro, Sector 107, Vishwakarma Road, Noida 201301, India.

School of Chemical Engineering, Yeungnam University, Gyeongsan-si 38541, Republic of Korea.

出版信息

Cancers (Basel). 2025 Mar 24;17(7):1082. doi: 10.3390/cancers17071082.

DOI:10.3390/cancers17071082
PMID:40227591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11988167/
Abstract

Cancer is complex because of the critical imbalance in genetic regulation as characterized by both the overexpression of oncogenes (OGs), mainly through mutations, amplifications, and translocations, and the inactivation of tumor-suppressor genes (TSGs), which entail the preservation of genomic integrity by inducing apoptosis to counter the malignant growth. Reviewing the intricate molecular interplay between OGs and TSGs draws attention to their cell cycle, apoptosis, and cancer metabolism regulation. In the present review, we discuss seminal discoveries, such as Knudson's two-hit hypothesis, which framed the field's understanding of cancer genetics, leading to the next breakthroughs with next-generation sequencing and epigenetic profiling, revealing novel insights into OG and TSG dysregulation with opportunities for targeted therapy. The key pathways, such as MAPK/ERK, PI3K/AKT/mTOR, and Wnt/β-catenin, are presented in the context of tumor progression. Importantly, we further highlighted the advances in therapeutic strategies, including inhibitors of KRAS and MYC and restoration of TSG function, despite which mechanisms of resistance and tumor heterogeneity pose daunting challenges. A high-level understanding of interactions between OG-TSGs forms the basis for effective, personalized cancer treatment-something to strive for in better clinical outcomes. This synthesis should integrate foundational biology with translation and, in this case, contribute to the ongoing effort against cancer.

摘要

癌症很复杂,因为其基因调控存在严重失衡,表现为癌基因(OGs)主要通过突变、扩增和易位过度表达,以及肿瘤抑制基因(TSGs)失活,肿瘤抑制基因通过诱导细胞凋亡来维持基因组完整性以对抗恶性生长。回顾OGs和TSGs之间复杂的分子相互作用,会让人关注它们在细胞周期、细胞凋亡和癌症代谢调控方面的作用。在本综述中,我们讨论了一些重大发现,比如克努森的二次打击假说,该假说奠定了该领域对癌症遗传学的理解基础,随后随着下一代测序和表观遗传学分析取得进一步突破,揭示了OG和TSG失调的新见解,为靶向治疗带来了机会。关键信号通路,如MAPK/ERK、PI3K/AKT/mTOR和Wnt/β-连环蛋白,在肿瘤进展的背景下进行了阐述。重要的是,我们进一步强调了治疗策略的进展,包括KRAS和MYC抑制剂以及TSG功能的恢复,尽管耐药机制和肿瘤异质性带来了严峻挑战。对OG-TSGs之间相互作用的深入理解构成了有效、个性化癌症治疗的基础,这是为实现更好临床结果而努力的方向。这种综合应将基础生物学与转化研究相结合,在这种情况下,有助于当前对抗癌症的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a2/11988167/4798748d977a/cancers-17-01082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a2/11988167/5f631b18fb82/cancers-17-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a2/11988167/79976a4f59e0/cancers-17-01082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a2/11988167/4798748d977a/cancers-17-01082-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a2/11988167/5f631b18fb82/cancers-17-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a2/11988167/79976a4f59e0/cancers-17-01082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74a2/11988167/4798748d977a/cancers-17-01082-g003.jpg

相似文献

1
Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes.探索癌症的基因交响乐:癌基因与肿瘤抑制基因之间的相互作用。
Cancers (Basel). 2025 Mar 24;17(7):1082. doi: 10.3390/cancers17071082.
2
Translational Advances in Oncogene and Tumor-Suppressor Gene Research.癌基因与肿瘤抑制基因研究的转化进展
Cancers (Basel). 2025 Mar 17;17(6):1008. doi: 10.3390/cancers17061008.
3
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview.人类癌症中肿瘤抑制基因功能的丧失:概述
Cell Physiol Biochem. 2018;51(6):2647-2693. doi: 10.1159/000495956. Epub 2018 Dec 12.
4
Recent progress in mouse models for tumor suppressor genes and its implications in human cancer.近年来肿瘤抑制基因小鼠模型的研究进展及其对人类癌症的意义。
Clin Med Insights Oncol. 2013 Jun 3;7:103-22. doi: 10.4137/CMO.S10358. Print 2013.
5
New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.癌症中微小RNA功能的新见解:癌基因-微小RNA-肿瘤抑制基因网络
Front Mol Biosci. 2017 Jul 7;4:46. doi: 10.3389/fmolb.2017.00046. eCollection 2017.
6
Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.癌基因与肿瘤抑制基因:比较基因组学与网络视角
BMC Genomics. 2015;16 Suppl 7(Suppl 7):S8. doi: 10.1186/1471-2164-16-S7-S8. Epub 2015 Jun 11.
7
DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.利用遗传和表观遗传特征发现癌基因和肿瘤抑制基因。
Sci Adv. 2020 Nov 11;6(46). doi: 10.1126/sciadv.aba6784. Print 2020 Nov.
8
The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.结直肠癌中肿瘤抑制基因、癌基因和微小RNA的共调控网络。
Genes Chromosomes Cancer. 2017 Nov;56(11):769-787. doi: 10.1002/gcc.22481. Epub 2017 Jul 30.
9
Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.卵巢癌中肿瘤抑制基因和癌基因的独特且竞争性的调控模式。
PLoS One. 2012;7(8):e44175. doi: 10.1371/journal.pone.0044175. Epub 2012 Aug 30.
10
Single-Hit Inactivation Drove Tumor Suppressor Genes Out of the X Chromosome during Evolution.单击失活在进化过程中导致肿瘤抑制基因从 X 染色体上丢失。
Cancer Res. 2022 Apr 15;82(8):1482-1491. doi: 10.1158/0008-5472.CAN-21-3458.

引用本文的文献

1
Effect of pyrogallol nanocomposite on miRNA and its associated pathways during radiation-induced toxicity in small intestine of irradiated Balb/C mice.连苯三酚纳米复合材料对受辐照Balb/C小鼠小肠辐射诱导毒性过程中miRNA及其相关通路的影响。
Med Oncol. 2025 Aug 30;42(10):457. doi: 10.1007/s12032-025-02989-7.
2
The Potential of Nutraceutical Supplementation in Counteracting Cancer Development and Progression: A Pathophysiological Perspective.营养保健品补充剂在对抗癌症发生和发展中的潜力:病理生理学视角
Nutrients. 2025 Jul 18;17(14):2354. doi: 10.3390/nu17142354.

本文引用的文献

1
Effect of palliative radiotherapy and cyclin-dependent kinase 4/6 inhibitor on breast cancer cell lines.姑息性放疗和细胞周期蛋白依赖性激酶4/6抑制剂对乳腺癌细胞系的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 4. doi: 10.1007/s00210-025-03878-6.
2
Clinical Validation of a Machine Learning-Based Biomarker Signature to Predict Response to Cytotoxic Chemotherapy Alone or Combined with Targeted Therapy in Metastatic Colorectal Cancer Patients: A Study Protocol and Review.基于机器学习的生物标志物特征预测转移性结直肠癌患者单纯细胞毒性化疗或联合靶向治疗反应的临床验证:一项研究方案及综述
Life (Basel). 2025 Feb 19;15(2):320. doi: 10.3390/life15020320.
3
Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology.
提高癌症治疗的精准度:基因治疗和免疫调节在肿瘤学中的作用。
Front Med (Lausanne). 2025 Jan 13;11:1527600. doi: 10.3389/fmed.2024.1527600. eCollection 2024.
4
Methods for multi-omic data integration in cancer research.癌症研究中的多组学数据整合方法。
Front Genet. 2024 Sep 19;15:1425456. doi: 10.3389/fgene.2024.1425456. eCollection 2024.
5
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future.MDM2 抑制剂在癌症治疗中的应用:过去、现在与未来。
Pharmacol Rev. 2024 May 2;76(3):414-453. doi: 10.1124/pharmrev.123.001026.
6
Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs.揭示癌症和神经退行性疾病中的细胞周期失调及其相关机制:重新利用药物的一线曙光。
Mol Neurobiol. 2024 Nov;61(11):8600-8630. doi: 10.1007/s12035-024-04130-7. Epub 2024 Mar 26.
7
Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review.人工智能与放射组学在膀胱癌、肾癌和前列腺癌中的新趋势:批判性综述
Cancers (Basel). 2024 Feb 16;16(4):810. doi: 10.3390/cancers16040810.
8
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies.基于细胞的免疫疗法中的免疫逃逸:揭示挑战与新策略。
J Biomed Sci. 2024 Jan 12;31(1):5. doi: 10.1186/s12929-024-00998-8.
9
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.靶向 RAS/RAF/MAPK 通路治疗癌症:从机制到临床研究。
Signal Transduct Target Ther. 2023 Dec 18;8(1):455. doi: 10.1038/s41392-023-01705-z.
10
Insights into fourth generation selective inhibitors of (C797S) EGFR mutation combating non-small cell lung cancer resistance: a critical review.针对(C797S)表皮生长因子受体(EGFR)突变的第四代选择性抑制剂对抗非小细胞肺癌耐药性的见解:一项批判性综述
RSC Adv. 2023 Jun 21;13(27):18825-18853. doi: 10.1039/d3ra02347h. eCollection 2023 Jun 15.